Skip to main content
. 2022 Aug 22:1–12. Online ahead of print. doi: 10.1007/s10238-022-00871-8

Table 5.

Percentage of responders, partial responders and non-responders for each outcome measure (comparison between groups)

Score Control group Treatment group All patients p value
FSS; n (%)
 Non-responders 15 (25.9) 11 (9.5) 26 (14.9) <0.0001
 Partial responders 41 (70.6) 43 (37.0) 84 (48.3)
 Responders 2 (3.5) 62 (53.5) 64 (36.8)
VAS fatigue; n (%)
 Non-responders 19 (32.8) 14 (12.0) 33 (19.0) <0.0001
 Partial responders 34 (58.6) 35 (30.2) 69 (39.7)
 Responders 5 (8.6) 67 (57.8) 72 (41.3)
VAS pain; n (%)
 Non-responders 33 (56.9) 19 (16.4) 52 (29.9) <0.0001
 Partial responders 25 (43.1) 37 (31.9) 62 (35.6)
 Responders 0 (0.0) 60 (51.7) 60 (34.5)
VAS sleep; n (%)
 Non-responders 19 (32.8) 11 (9.5) 30 (17.2) <0.0001
 Partial responders 34 (58.6) 32 (27.6) 66 (37.9)
 Responders 5 (8.6) 73 (62.9) 78 (44.9)
WPI; n (%)
 Non-responders 24 (41.4) 13 (11.2) 37 (21.2) <0.0001
 Partial responders 29 (50.0) 16 (13.8) 45 (25.9)
 Responders 5 (8.6) 87 (75.0) 92 (52.9)
FAS; n (%)
 Non-responders 22 (37.9) 6 (5.2) 28 (16.1) <0.0001
 Partial responders 34 (58.6) 26 (22.4) 60 (34.5)
 Responders 2 (3.5) 84 (72.4) 86 (29.4)
SSS; n (%)
 Non-responders 9 (15.5) 9 (7.8) 18 (10.3) <0.0001
 Partial responders 44 (75.9) 19 (16.4) 63 (36.2)
 Responders 5 (8.6) 88 (75.8) 93 (53.5)